Curium strikes up to $8 billion deal for radiopharma peer Lantheus
Curium has agreed to buy radiopharmaceutical company Lantheus Holdings in a deal worth up to $8 billion, the companies said on Monday.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
